BHIVA BASSH joint conference 2026: New modelling estimates scale of PrEP expansion needed to support England’s HIV elimination ambitions
Aquarius Population Health presented new modelling research at the BHIVA BASSH joint conference 2026, 27th -29th April, estimating the additional number of people that may need to receive PrEP between 2026 and 2030 to help England meet its 2030 HIV transmission elimination goal. England has committed to ambitious HIV transmission elimination targets by 20301. Although Read More >
When will the UK achieve HIV transmission elimination? Modelling the impact of current HIV prevention efforts on progress towards the 2030 elimination goal
In 2019, the previous UK government set the ambitious target of eliminating HIV transmission within the UK by 2030. While great progress has been made in HIV prevention and treatment in the UK, with England reaching the UNAIDS 95-95-95 target in 20231, past evidence suggested that the goal of ‘elimination’ by 2030 is unlikely to Read More >
Looking at the cost implications of using PCR-based respiratory panel assays for patients admitted to hospital with pneumonia in the UK, France and Spain
Our paper on the cost of using PCR-based respiratory panel assays for patients with pneumonia was published this week in BMC Pulmonary Medicine. This work, funded by the Innovative Health Initiative (IHI), compared the cost of using standard diagnostic tests with the cost of using either an upper respiratory pathogen PCR-based panel test, a lower Read More >
Exploring the cost-effectiveness of focused ultrasound in treating Essential Tremor in England
Medically refractory Essential Tremor (mrET) is the most common movement disorder affecting approximately 1 million in the United Kingdom and can be disabling. Medical treatment is not always successful at controlling tremors. Deep Brain Stimulation (DBS) is a proven neurosurgical treatment; however, the risks of surgery and anaesthesia mean some patients are ineligible for DBS. Read More >
Further evidence that point of care (POC) testing for STIs means better clinical care for patients
Most people are now familiar with using rapid diagnostic tests with many people regularly using lateral flow tests for COVID-19. Within sexual health clinics, rapid testing for HIV has been widely used for a number of years but using rapid tests for other sexually transmitted infections (STIs) such as chlamydia and gonorrhoea is not yet Read More >
Analysing the COPD care pathway in Japan, Canada, England and Germany: a global view
Aquarius Population Health are delighted to be collaborating with AstraZeneca on a poster session at this year’s European Respiratory Society International Congress. Our research, based on clinician interviews and local data reviews, advances our understanding of COPD care pathways in Japan, Canada, England and Germany, and identifies cross cutting barriers to optimal COPD care, which Read More >
Aquarius part of collaborative NIHR grant to evaluate Odin Vision’s artificial intelligence technology to fight bowel cancer
In the UK, 42,000 new diagnoses and 16,000 deaths occur from bowel cancer each year. Bowel cancer is the second most common cause of cancer death in the UK, comprising over 10% of all deaths due to cancer. (1) A recent study found that almost one third of bowel cancer patients experience an avoidable delay Read More >
How much would community-based screening for chlamydia and gonorrhoea cost?
We collaborated with St George’s, University of London, on a NIHR-funded study ‘Test n Treat’ (TnT). This study assessed the cost of providing same-day chlamydia and gonorrhoea testing and treatment service at higher education colleges. The paper presenting this work was published in BMC Health Services Research and is now available online. Read More >
Could a same day test and treatment service in further education colleges improve uptake of chlamydia testing among young people?
Aquarius were part of a recent feasibility trial looking at whether provision of a same day test and treatment service for chlamydia in further education colleges increased uptake of chlamydia testing and treatment. The results of the trial were published this week in Clinical Microbiology and Infection and are available online. Read More >
Evaluating multi-bug point-of-care tests for diagnosing STIs
New point-of-care (POC) tests are currently being developed which can be used in clinic to simultaneously test for multiple sexually transmitted infections (STIs). In work now published online in BMJ Open, we developed a model to compare three possible strategies for POC STI testing with the current practice of microscopy and lab-based testing. The three Read More >